Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell line

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Kojima, Reiji ^a,b   Ohno, Tatsukuni ^b,h   Iikura, Motoyasu ^c   Niki, Toshiro ^d,e   Hirashima, Mitsuomi ^d,e   Iwaya, Keichi ^a   Tsuda, Hitoshi ^a   Nonoyama, Shigeaki ^a   Matsuda, Akio ^b   Saito, Hirohisa ^b   Matsumoto, Kenji ^b   Nakae, Susumu ^b,f,g  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d KAGAWA UNIVERSITY   (Japan)

^e Departments of Immunology and Immunopathology Faculty of Medicine Kagawa University ^*  (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^h TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ECALECTIN; IONOMYCIN; LECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 12; MITOGEN ACTIVATED PROTEIN KINASE 3; GALECTIN; LGALS9 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MAST CELL DEGRANULATION; PROTEIN FUNCTION; CELL LINE; DEGRANULATION; MAST CELL; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

APOPTOSIS; CELL DEGRANULATION; CELL LINE; CELL SURVIVAL; CYTOKINES; ENZYME ACTIVATION; GALECTINS; HUMANS; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION;

EID: 84919377889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086106     Document Type: Article

References (37)

1. Matsumoto R, Hirashima M, Kita H, Gleich GJ (2002) Biological activities of ecalectin: a novel eosinophil-activating factor. J Immunol 168: 1961-1967. (Pubitemid 34135799)
2. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, et al. (1998) Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 273: 16976-16984. (Pubitemid 28311730)
3. Matsushita N, Nishi N, Seki M, Matsumoto R, Kuwabara I, et al. (2000) Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J Biol Chem 275: 8355-8360. (Pubitemid 30180176)
4. Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, et al. (2002) Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol 169: 5912-5918. (Pubitemid 35291697)
5. Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi TA, et al. (2004) Galectin-9 in physiological and pathological conditions. Glycoconj J 19: 593-600. (Pubitemid 38460942)
6. Seki M, Sakata KM, Oomizu S, Arikawa T, Sakata A, et al. (2007) Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum 56: 3968-3976. (Pubitemid 350262324)
7. Wada J, Ota K, Kumar A, Wallner EI, Kanwar YS (1997) Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest 99: 2452-2461. (Pubitemid 27227724)
8. Rabinovich GA, Liu FT, Hirashima M, Anderson A (2007) An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scand J Immunol 66: 143-158. (Pubitemid 47063211)
9. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, et al. (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6: 1245-1252. (Pubitemid 43045636)
10. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, et al. (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541. (Pubitemid 34130609)
11. Nakae S, Iwakura Y, Suto H, Galli SJ (2007) Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 81: 1258-1268. (Pubitemid 46702045)
12. Ndhlovu LC, Lopez-Verges S, Barbour JD, Jones RB, Jha AR, et al. (2012) Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 119: 3734-3743.
13. Liu Y, Shu Q, Gao L, Hou N, Zhao D, et al. (2010) Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clin Immunol 137: 288-295.
14. Tang ZH, Liang S, Potter J, Jiang X, Mao HQ, et al. (2013) Tim-3/galectin-9 regulate the homeostasis of hepatic NKT cells in a murine model of nonalcoholic fatty liver disease. J Immunol 190: 1788-1796.
15. Anderson AC, Anderson DE, Bregoli L, Hastings WD, Kassam N, et al. (2007) Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318: 1141-1143. (Pubitemid 350134897)
16. Nakae S, Iikura M, Suto H, Akiba H, Umetsu DT, et al. (2007) TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood 110: 2565-2568. (Pubitemid 47523180)
17. Wiener Z, Kohalmi B, Pocza P, Jeager J, Tolgyesi G, et al. (2007) TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells. J Invest Dermatol 127: 906-914. (Pubitemid 46434647)
18. Nobumoto A, Oomizu S, Arikawa T, Katoh S, Nagahara K, et al. (2009) Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice. Clin Immunol 130: 322-330.
19. Nagahara K, Arikawa T, Oomizu S, Kontani K, Nobumoto A, et al. (2008) Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J Immunol 181: 7660-7669.
20. Irie A, Yamauchi A, Kontani K, Kihara M, Liu D, et al. (2005) Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer. Clin Cancer Res 11: 2962-2968. (Pubitemid 40525199)
21. Kageshita T, Kashio Y, Yamauchi A, Seki M, Abedin MJ, et al. (2002) Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer 99: 809-816. (Pubitemid 34575697)
22. Wiersma VR, de Bruyn M, van Ginkel RJ, Sigar E, Hirashima M, et al. (2012) The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells. J Invest Dermatol 132: 2302-2305.
23. Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, et al. (2008) Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127: 78-88.
24. Kearley J, McMillan SJ, Lloyd CM (2007) Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J Exp Med 204: 1289-1294. (Pubitemid 46919866)
25. Sziksz E, Kozma GT, Pallinger E, Komlosi ZI, Adori C, et al. (2010) Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. Int Arch Allergy Immunol 151: 308-317.
26. Yamamoto H, Kashio Y, Shoji H, Shinonaga R, Yoshimura T, et al. (2007) Involvement of galectin-9 in guinea pig allergic airway inflammation. Int Arch Allergy Immunol 143 Suppl 1: 95-105. (Pubitemid 46854801)
27. Katoh S, Ishii N, Nobumoto A, Takeshita K, Dai SY, et al. (2007) Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med 176: 27-35. (Pubitemid 47048051)
28. Barlow JL, Wong SH, Ballantyne SJ, Jolin HE, McKenzie AN (2011) Tim1 and Tim3 are not essential for experimental allergic asthma. Clin Exp Allergy 41: 1012-1021.
29. Niki T, Tsutsui S, Hirose S, Aradono S, Sugimoto Y, et al. (2009) Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem 284: 32344-32352.
30. Butterfield JH, Weiler D, Dewald G, Gleich GJ (1988) Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12: 345-355.
31. Yagami A, Orihara K, Morita H, Futamura K, Hashimoto N, et al. (2010) IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol 185: 5743-5750.
32. Ho LH, Ohno T, Oboki K, Kajiwara N, Suto H, et al. (2007) IL-33 induces IL- 13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukoc Biol 82: 1481-1490. (Pubitemid 350276960)
33. Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, et al. (2007) IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 87: 971-978. (Pubitemid 47429189)
34. Dai SY, Nakagawa R, Itoh A, Murakami H, Kashio Y, et al. (2005) Galectin-9 induces maturation of human monocyte-derived dendritic cells. J Immunol 175: 2974-2981. (Pubitemid 41170515)
35. Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, et al. (2003) Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 170: 3631-3636. (Pubitemid 36359232)
36. Nakayama M, Akiba H, Takeda K, Kojima Y, Hashiguchi M, et al. (2009) Tim- 3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113: 3821-3830.
37. Xia HZ, Kepley CL, Sakai K, Chelliah J, Irani AM, et al. (1995) Quantitation of tryptase, chymase, Fc epsilon RI alpha, and Fc epsilon RI gamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J Immunol 154: 5472-5480.